Press release
Investigation announced for Long-Term Investros in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares over potential Wrongdoing
An investigation on behalf of current long term investors in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares.
Investors who are current long term investors in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: VRCA stocks follows a lawsuit filed against Verrica Pharmaceuticals Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: VRCA stocks, concerns whether certain Verrica Pharmaceuticals Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges that, the Defendants failed to disclose to investors that there were manufacturing deficiencies at the facility where Verrica Pharmaceuticals' contract manufacturer produced bulk solution for VP-102, that these deficiencies were not remediated when Verrica Pharmaceuticals resubmitted its NDA for VP-102, that the foregoing presented significant risks to Verrica Pharmaceuticals obtaining regulatory approval of VP-102, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investros in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares over potential Wrongdoing here
News-ID: 2752848 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Verrica
Genital Warts Market Outlook Report | Verrica Pharmaceuticals, Novan Inc., G&E H …
DelveInsight's "Genital Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Genital Warts, historical and forecasted epidemiology as well as the Genital Warts market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Genital Warts market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Genital Warts market size…
Verrica Pharmaceuticals "VP-102" Market size expansion of Several Folds by 2032
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on VP-102 (Verrica Pharmaceuticals) providing insights into the drug market landscape and market forecast of VP-102 upto 2032. The report, titled "VP-102 Market Size, Forecast, and Emerging Insight - 2032" is now available for review and analysis.
Are you interested in finding out the projected market size of VP-102 in 2032? VP-102 Market…
Common Warts Market to Witness Growth by 2032 | Nielsen BioSciences, Veloce BioP …
DelveInsight's "Common Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Common Warts, historical and forecasted epidemiology as well as the Common Warts market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Common Warts market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Common Warts market size…
Genital Warts Market Size And Forecast - 2023-2031 | Cipla Ltd., GlaxoSmithKline …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Genital Warts Market.
The Genital Warts Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy. The Genital Warts…
Lawsuit filed for Investors in shares of Verrica Pharmaceuticals Inc. (NASDAQ: V …
An investor, who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), filed a lawsuit over alleged Securities Laws violations by Verrica Pharmaceuticals Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) ou have certain options and for certain investors are short and strict deadlines running. Deadline: August 5, 2022. NASDAQ: VRCA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Investigation announced for Investors in shares of Verrica Pharmaceuticals Inc. …
An investigation was announced concerning potential securities laws violations by Verrica Pharmaceuticals Inc. in connection with certain financial statements.
Investors who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) concerning whether a…
